InsidersTradesSigma
Follow the GILEAD SCIENCE share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). The latest transaction was disclosed on 26 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: ANTHONY WELTERS. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Gilead Science is a biopharmaceutical company focused on the research and development of medicines to treat serious diseases, including viral infections and cancer.